Lv61
2700 积分 2021-05-31 加入
Clinical Implications of a New DDX58 Pathogenic Variant That Causes Lupus Nephritis due to RIG-I Hyperactivation
1小时前
待确认
JAK inhibitors in systemic lupus erythematosus: Translating pathogenesis into therapy
1个月前
已完结
The immunology of systemic lupus erythematosus
1个月前
已完结
New and emerging therapies for systemic lupus erythematosus
1个月前
已完结
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
1个月前
已完结
Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?
2个月前
已完结
Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients
2个月前
已完结
Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus
2个月前
已完结
Additional benefits of belimumab in chronic phase of systemic lupus erythematosus and efficacy of tacrolimus combination therapy
2个月前
已完结
Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomised clinical trials of belimumab
2个月前
已完结
皖公网安备34019202002308
